Evidence map›Paper›PMID 42706153›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2026

[Allogeneic hematopoietic stem cell transplantation for 510 patients with active relapsed/refractory acute myeloid leukemia: a real-world study].

X Y Man, M L Li, X H Fei, H Y Cheng, Y M Yin, R M Luo, S Q Zhang, J Y Gu, S Xue, W J Zhang and 11 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

X Y ManDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
M L LiDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
X H FeiDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
H Y ChengDepartment of Bone Marrow Transplantation, Beijing Lu Daopei Hospital, Beijing 101102, China.
Y M YinDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
R M LuoDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
S Q ZhangDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
J Y GuDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
S XueUniversity Hospital, Beijing University of Chemical Technology, Beijing 100029, China.
W J ZhangDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
F YangDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
Q H ManDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
Y X YangDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
Z Q TianDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
T T LiDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
L YuanDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
H X WenDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
W WeiDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
W J WangDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
Y WangDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.
J B WangDepartment of Hematology, Aerospace Center Hospital, Beijing 100049, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteAdolescentAdultDisease-Free SurvivalFemaleHumansMaleMiddle AgedPrognosisRecurrenceRetrospective StudiesSalvage TherapyTransplantation, HomologousTreatment OutcomeYoung AdultActive diseaseAllogeneic hematopoietic stem cell transplantationLeukemia, myeloid, acuteRelapsed/refractory

Identifiers

PMID42706153
PMCPMC13575536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.